During the past decade, Fondation du centre Pluridisciplinaire d'Oncologie (CePO) conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fondation du centre Pluridisciplinaire d'Oncologie (CePO)" #1 collaborator was "Biodesix, Inc." with 1 trials as a collaborator and "Spanish Lung Cancer Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Fondation du centre Pluridisciplinaire d'Oncologie (CePO)" are "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Lung Cancer" (1 trials). Many other conditions were trialed in "Fondation du centre Pluridisciplinaire d'Oncologie (CePO)" in a lesser frequency.

Most popular intervention types in "Fondation du centre Pluridisciplinaire d'Oncologie (CePO)" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Erlotinib" (2 trials), "Bevacizumab" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fondation du centre Pluridisciplinaire d'Oncologie (CePO)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Fondation du centre Pluridisciplinaire d'Oncologie (CePO)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Fondation du centre Pluridisciplinaire d'Oncologie (CePO), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fondation du centre Pluridisciplinaire d'Oncologie (CePO), 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".